Skip to main content
logo
XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.780
+0.018 (0.65%)
At close: Aug 21, 2026, 4:00 PM EDT
2.660
-0.120 (-4.32%)
After-hours: Aug 21, 2026, 7:15 PM EDT

XTL Biopharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.97-1.03-1.78-1.350.44
Depreciation & Amortization
-0.2-00
Loss (Gain) From Sale of Assets
6.21----
Asset Writedown & Restructuring Costs
0.22----
Loss (Gain) From Sale of Investments
-0.01-0.171.021.53-0.75
Stock-Based Compensation
0.350.2600.010.04
Provision & Write-off of Bad Debts
0.31----
Other Operating Activities
-1.14-1.08-0.01-1.08-0.72
Change in Accounts Receivable
0.160.04---
Change in Accounts Payable
-0.190.210.02-0.04-0.02
Change in Other Net Operating Assets
0.03-0.060.050.03-0.03
Operating Cash Flow
-1.03-1.62-0.71-0.9-1.05
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.05---
Cash Acquisitions
--0.41---
Investment in Securities
0.78-0.01---
Other Investing Activities
-0.010.030.040.040.01
Investing Cash Flow
0.52-0.840.040.040.01

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
0.21----
Long-Term Debt Repaid
--0.01---
Net Debt Issued (Repaid)
0.21-0.01---
Issuance of Common Stock
-1.46--0.39
Financing Cash Flow
0.211.45--0.39

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
--0.02-0.03-0.01-0.01
Net Cash Flow
-0.3-1.03-0.69-0.88-0.66

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.03-1.67-0.71-0.9-1.05
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00
Levered Free Cash Flow
-2.121.61-0.41-0.55-0.66
Unlevered Free Cash Flow
-2.111.63-0.41-0.55-0.66

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-00.190.06-0.02-0.05
SEC Filings: 10-K · 10-Q